Andrew Holmes

Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response

Evandro de Azambuja, Andrew Holmes, Martine Piccart et al. · The Lancet Oncology · 2014 · 452 citations

Survival Outcomes, Breast Oncology, Medicine +7

Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial

Martine Piccart, Eileen Holmes, José Baselga et al. · Journal of Clinical Oncology · 2015 · 370 citations · Full text

Sustainable flood memories, lay knowledges and the development of community resilience to future flood risk

Lindsey McEwen, Joanne Garde‐Hansen, Andrew Holmes et al. · Transactions of the Institute of British Geographers · 2016 · 169 citations · Full text

Resilience (Structural Engineering), Engineering, Flood Control +24

First results from the phase III ALTTO trial (BIG 2-06; NCCTG [Alliance] N063D) comparing one year of anti-HER2 therapy with lapatinib alone (L), trastuzumab alone (T), their sequence (T→L), or their combination (T+L) in the adjuvant treatment of HER2-positive early breast cancer (EBC).

Martine Piccart, Andrew Holmes, José Baselga et al. · Journal of Clinical Oncology · 2014 · 143 citations

Breast Oncology, Immunology, Pathology +18

‘Learning for resilience': Developing community capital through flood action groups in urban flood risk settings with lower social capital

Lindsey McEwen, Andrew Holmes, Nevil Quinn et al. · International Journal of Disaster Risk Reduction · 2017 · 93 citations

Public Policy, Flood Action Groups, Community Development +15